BioSpace News Archive

FDA

CytoDyn Announces Productive Pre-BLA Meeting with FDA for PRO 140 Combination Therapy

Rolling BLA Submission Starting as Early as the End of 2018

July 5, 2018
·
6 min read
Job Trends

Matrix Medical Network to Present at 2018 RISE Quality Leadership Summit

Matrix Medical Network will co-present a special session on how physicians are using new strategies to close care gaps at the Third Annual RISE Quality Leadership Summit in Phoenix, Arizona.

July 5, 2018
·
2 min read
Business

MaRS Innovation appoints Steven Chackowicz as Executive-in-Residence

MaRS innovation (MI) announced that Steven Chackowicz has been appointed Executive-in-Residence where he will oversee the technology scouting and commercialization efforts for MI in the medical device space.

July 5, 2018
·
2 min read
Business

CNL HEALTHCARE PROPERTIES ANNOUNCES SPECIAL COMMITTEE, NAMES FINANCIAL ADVISORS TO CONSIDER STRATEGIC ALTERNATIVES

CNL Healthcare Properties announced that the board of directors has appointed a special committee of its independent board members to evaluate strategic alternatives to provide liquidity to shareholders, and has now named financial advisors to assist in the process.

July 5, 2018
·
2 min read
Business

Earth Science Tech, Inc. Aligns with AATAC to Reach up to 90,000 Retail Outlets

Earth Science Tech, Inc. signs agreement to work collectively with AATAC to present the “ETST” product line to their vast network of approximately 90,000 retail outlets throughout the U.S.

July 5, 2018
·
5 min read
Biotech Beach

GS Medical Announces New Product Launch and Successful Cadaver Workshop

GS Solutions Inc., DBA GS Medical USA (GSM) announced the launch of the AnyPlus® Extended Tab Minimally Invasive Pedicle Screw system.

July 5, 2018
·
2 min read
Drug Development

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

Patient enrollment proceeding under amended protocol

July 5, 2018
·
6 min read
Business

RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso

RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of Directors (“Board”) of the Company, effective as of September 30, 2018

July 5, 2018
·
8 min read
Policy

Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development ProgramApproval of Vitality research program and manufacturing operations through May 2019

Vitality Biopharma, Inc. announced that it has received approval from both the U.S. Drug Enforcement Administration (DEA) and the State of California Research Advisory Panel which permits the Company to continue development of its novel cannabinoid pharmaceutical prodrugs.

July 5, 2018
·
3 min read
Deals

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis

July 5, 2018
·
4 min read